The Reserve Bank of India maintained its existing monetary policy stance, emphasizing caution amid persistent inflationary risks and uneven global economic conditions. The central bank reaffirmed its commitment to price stability while remaining attentive to domestic growth dynamics. Policymakers underscored the need for continued vigilance as food prices, global interest rate uncertainty, and geopolitical tensions pose challenges to the macroeconomic outlook.

Maruti Suzuki India Ltd. plans to set up modern driving test tracks in Andhra Pradesh, marking a strategic expansion of its road safety and driver training initiatives. The project aims to support state authorities in strengthening licensing standards while promoting responsible driving practices. By leveraging technology-driven testing infrastructure, the initiative is expected to improve transparency, efficiency, and accuracy in evaluating driving skills.

Shares of Life Insurance Corporation of India surged in trading after the state-run insurer reported a robust set of earnings for the third quarter, surpassing market expectations. The rally reflects renewed investor confidence in LIC’s improving profitability, disciplined cost management, and stabilizing business metrics. Market participants responded positively to signs of margin expansion and improved operational efficiency, viewing the results as evidence of a gradual turnaround following earlier volatility.

Indian equity benchmarks closed lower as investors adopted a wait-and-watch approach ahead of the Reserve Bank of India’s monetary policy announcement. Market sentiment remained subdued amid uncertainty over the central bank’s stance on interest rates, inflation management, and liquidity conditions. Broad-based selling was seen across sectors, with financials and rate-sensitive stocks facing notable pressure. Global cues offered limited support, while domestic investors remained focused on macroeconomic signals.

Hero MotoCorp delivered a solid financial performance in the third quarter, reporting a 15% year-on-year increase in consolidated net profit to Rs 1,275 crore. The earnings growth reflects improved operational efficiency, disciplined cost management, and a gradual recovery in domestic demand for two-wheelers. Despite persistent challenges such as input cost volatility and competitive pressure, the company managed to protect margins and strengthen profitability.

Thomas Cook India’s Q3 financial results reflect a decline in net profit, primarily due to increased expenditures related to compliance with new labour codes and rising operational costs in the travel and tourism sector. The company continues to navigate a challenging environment marked by fluctuating travel demand and regulatory adjustments. Despite the profit dip, revenue from core travel services remained stable, indicating sustained customer engagement.

Emami Ltd is intensifying its focus on rural markets, leveraging rising consumption trends and festival-driven demand to fuel growth. The company expects a significant uptick in summer sales, supported by targeted marketing campaigns and the expansion of its distribution network into underpenetrated rural regions. Key product categories, including personal care, healthcare, and wellness segments, are expected to drive volume growth. Emami’s strategy emphasizes localized promotions, strengthened dealer partnerships, and innovative packaging to appeal to rural consumers.

Godrej Properties Ltd (GPL) posted a 23% year-on-year increase in net profit for the third quarter, reaching Rs 194 crore, driven by robust sales momentum and strategic project execution. The company’s revenue growth reflects sustained demand across residential and commercial real estate segments, particularly in metropolitan and tier-2 cities. Operational efficiencies, timely project launches, and a strong sales pipeline contributed to improved margins.

Sun Pharmaceutical Industries Ltd is investing Rs 500 crore to establish a new state-of-the-art manufacturing plant in Assam, underscoring its commitment to expanding production capacity and strengthening its presence in India’s northeast. The facility will focus on high-demand formulations, enhancing supply chain efficiency and catering to domestic and international markets. This strategic investment aligns with Sun Pharma’s broader growth agenda of optimizing operational capabilities while leveraging regional advantages.

JSW Cement posted a net profit of Rs 130.62 crore for the third quarter of FY26, reflecting resilient operational performance amid fluctuating input costs. The company’s revenue increased on a year-on-year basis, driven by steady demand in both domestic and key export markets. Analysts highlighted that JSW Cement’s strategic focus on cost optimization, enhanced distribution networks, and efficiency improvements contributed to its earnings stability.